aspsirna2169 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna2169
siRNA Name: K12-Leu140Arg-9
Gene:Keratin 12 (KRT12)
Disease:Meesmann epithelial corneal Dystrophy (MECD)
Wild allele/target (5'->3'): AUGCAAAAUCAUAAUGAUA
Mutant allele/target (5'->3'):AUGCAAAAUCCUAAUGAUA
Target Mutation: c.419T>G,p.Leu140Arg
Wild siRNA (As strand):UACGUUUUAGUAUUACUAU
ASP-siRNA (As strand):UACGUUUUAGGAUUACUAU
Mismatch position in siRNA: G9U
Mutant allele (5'->3'): AUGCAAAAUCCUAAUGAUA
ASP-siRNA (As strand):UACGUUUUAGGAUUACUAU
ASP-siRNA efficacy for mutant allele:89
Wild allele (5'->3'): AUGCAAAAUCAUAAUGAUA
ASP-siRNA (As strand):UACGUUUUAGGAUUACUAU
ASP-siRNA efficacy for wild allele:8
Percentage discrimination for ASP-siRNA:81
Wild allele (5'->3'): AUGCAAAAUCAUAAUGAUA
Wild siRNA (As strand):UACGUUUUAGUAUUACUAU
Wild sirna efficacy for wild allele:45
Wild allele (5'->3'): AUGCAAAAUCAUAAUGAUA
ASP-siRNA (As strand):UACGUUUUAGGAUUACUAU
Wild sirna efficacy for mutant allele:60
Percentage discrimination for wild siRNA:-15
Concentration:5nM
Orientation:Double strand
Mismatch in:siRNA
UniProt ID: Q99456
Target sequence: CCTAATGATAGATTAGCTTCCTACCTGG
Genbank Accesion: NM_000223.3
Cell-line: AD293
Experimental technique used: Western blot
Transfection method: Lipofectamine 2000
siRNA expression method: Invitrogen
Post-transfection duration: 24/48/72hours
OMID ID: 122100
KEGG disease ID:H00726
Reference:24801514

.
.
.
.
.
.
.
.
.
.
.

.

.

.